0001104659-22-007844.txt : 20220126 0001104659-22-007844.hdr.sgml : 20220126 20220126163155 ACCESSION NUMBER: 0001104659-22-007844 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220124 FILED AS OF DATE: 20220126 DATE AS OF CHANGE: 20220126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Einhorn Andrew J. CENTRAL INDEX KEY: 0001560685 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38709 FILM NUMBER: 22558412 MAIL ADDRESS: STREET 1: C/O MYOS CORPORATION STREET 2: 45 HORSEHILL ROAD, SUITE 106 CITY: CEDAR KNOLLS STATE: NJ ZIP: 07927 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RVL Pharmaceuticals plc CENTRAL INDEX KEY: 0001739426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 CROSSING BOULEVARD CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 9088091300 MAIL ADDRESS: STREET 1: 400 CROSSING BOULEVARD CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: Osmotica Pharmaceuticals plc DATE OF NAME CHANGE: 20180906 FORMER COMPANY: FORMER CONFORMED NAME: Osmotica Pharmaceuticals Ltd DATE OF NAME CHANGE: 20180502 4 1 tm223506-4_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-01-24 0 0001739426 RVL Pharmaceuticals plc RVLP 0001560685 Einhorn Andrew J. C/O RVL PHARMACEUTICALS PLC 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 0 1 0 0 Chief Financial Officer Ordinary Shares 2022-01-24 4 F 0 9607 1.13 D 141473 D Ordinary Shares 22852 I By family limited liability company The Reporting Person is the sole managing member of the limited liability company and, as a result, may be deemed to beneficially own the ordinary shares held by the limited liability company. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. /s/ Christopher Klein, as attorney-in-fact 2022-01-26